Acute and chronic hypoxia might lead to different biology within the tumour and this might have a direct effect on the design of new therapies for the treatment of hypoxic tumours. Most solid ...

"Muscle microvasculature responds to hypoxia by dilating in an attempt ... timely diagnosis often poses a challenge to the treatment of chronic limb-threatening ischemia. Korpisalo notes that ...

Treatment can involve oxygen therapy and medications ... Other symptoms can occur from hypoxia, which happens when your blood doesn’t have enough oxygen. Hypoxia may occur at the same time ...

A collaborative study published on January 21 in Nature Communications presents a novel strategy to improve the effectiveness ...

Merck (MRK) announced that the European Commission has conditionally approved WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor, ...

Moderate to severe obstructive sleep apnea was associated with significantly higher odds of having neovascular age-related ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has conditionally approved WELIREG® (belzutifan), Merck’s oral ...